Recent Finacing
Recent Raise
EyeD Pharma develops microscale intraocular implants under one‑third millimeter thickness that deliver nanogram‑level ophthalmic drugs for up to three years, operates a CDMO manufacturing unit, and commercializes surgical equipment.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
